Profile Picture
Rewards
  • Search
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
    • Real Estate
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Running for Congress
Accused of gang rape
Comments on set photo leaks
Diagnosed with cancer
Sells song catalog
‘I felt so betrayed’
To sign executive order
Broadway debut in 'Chicago'
6 fake electors indicted
Panthers move training camp
Stylist Ralph Cirella dies
Ala. senator endorses Trump
To undergo surgery
Plans to sell chips in China
‘Masters of the Air' trailer
'RuPaul's Drag Race' cast
'Good Grief' trailer
Texas A&M hires Klein
Renewed for season 2
To open 10K restaurants?
Launches AI model ‘Gemini’
Titans sign Ty Zentner
Pirates acquire Gonzales
Hires Mason as head coach
Rams sign Mason Crosby
103K jobs added in Nov.
Hornets president resigns
US charges four Russians
‘The Traitors’ season 2
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
282,000 results
1d
Alzheimer's Disease Drug Development: Another Lost Year
Investing in most current Alzheimer's drug companies is not recommended because they are not likely to modify the disease.
Medical Xpress17d
New Alzheimer's drug shines light on need for assessments to head off 'a tsunami of cognitive afflictions'
Medicare will cover new class of Alzheimer's drugs if fully approved by FDA, with limits Jun 2, 2023 The real costs of the new Alzheimer's drug, most of which will fall to taxpayers Aug 14, 2023 ...
Hosted on MSN14d
Wake Forest and Duke University holding clinical trials for an FDA-approved drug to prevent Alzheimer's
Two North Carolina universities are conducting clinical trials involving a Food and Drug Administration-approved drug for Alzheimer’s, and they need volunteers to test it out. The new AHEAD ...
Live 5 News on MSN2d
Bluffton man among first to receive new Alzheimer’s drug: ‘It gives us hope’
BLUFFTON, S.C. (WCSC) - One of the first Alzheimer’s patients in the Lowcountry to take part in Leqembi infusion treatments ...
9d
What To Know About Metformin: The Decades-Old Diabetes Drug Fueling Billions in Longevity Research
American mortality is at the youngest it has been in almost two decades. But could repurposing a decades-old diabetes drug ...
2d
The Pentagon Wants to Root Out Shoddy Drugs. The FDA Is In Its Way.
One morning in October, US Army Colonel Victor Suarez finished his usual morning workout — a 32-mile bike ride — and then sat ...
WTSP29d
New research at USF Health could lead to breakthrough in treating Alzheimer's
TAMPA, Fla. — November is Alzheimer's Awareness Month. It's estimated that 1 in 8 Floridians are currently living with the disease and are supported by more than 800,000 unpaid family caregivers.
Reader's Digest Canada on MSN
1d
Dementia Breakthroughs Offer New Hope
New treatments and tests for dementia are finally here, after decades of disappointments The post Dementia Breakthroughs ...
Northwest Arkansas Democrat Gazette
1d
Alzheimer’s advisory council wants state to provide $300,000 for awareness campaign addressing brain health, dementia
The Alzheimer's Disease and Dementia Advisory Council wants state lawmakers to provide $300,000 in state funding for a public ...
RealClearMarkets21d
The FDA Is Too Aggressive About Blocking Life-Saving Drugs
When my friend Ira was diagnosed with Pancreatic cancer he went through surgery and chemotherapy, but was still facing a short life expectancy. Then he was lucky to be 1 of only 26 patients in an ...
WXII 12 NEWS14d
Wake Forest and Duke University holding clinical trials for an FDA-approved drug to prevent Alzheimer's
ABOUT A STUDY INVOLVING AN FDA APPROVED DRUG FOR ALZHEIMER’S. THE STUDY IS CALLED AHEAD AND BOTH DUKE AND WAKE FOREST UNIVERSITIES ARE CONDUCTING CLINICAL TRIALS THAT YOU MAY BE ABLE TO JOIN.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices